Litcius/Paper detail

Primary Results From Apollo-B, A Phase 3 Study Of Patisiran In Patients With Transthyretin-Mediated Amyloidosis With Cardiomyopathy

Matthew J. Maurer, Marianna Fontana, John L. Berk, Finn Gustafsson, Marcus Vinı́cius Simões, Martha Grogan, Fábio Fernandes, Robert Gottlieb, Miloš Kubánek, Steen Hvitfeldt Poulsen, Thibaud Damy, Igor Diemberger, Nobuhiro Tahara, WEN‐CHUNG YU, W.H. Wilson Tang, Laura Obici, Alejandra González‐Duarte, Yoshiki Sekijima, Matthew T. White, Seth Arum, Patrick Y. Jay, John Vest, Julian D. Gillmore

2023Journal of Cardiac Failure19 citationsDOI

Topics & Concepts

MedicineAmyloidosisCardiac amyloidosisCardiomyopathyPlaceboInternal medicineClinical endpointTransthyretinClinical trialHeart failurePathologyAlternative medicineAmyloidosis: Diagnosis, Treatment, OutcomesNeuroendocrine Tumor Research Advances
Primary Results From Apollo-B, A Phase 3 Study Of Patisiran In Patients With Transthyretin-Mediated Amyloidosis With Cardiomyopathy | Litcius